Ion Beam Applications SA (EBR:IBAB)

Market Cap	297.11M
Revenue (ttm)	465.75M
Net Income (ttm)	7.85M
Shares Out	28.90M
EPS (ttm)	0.27
PE Ratio	38.18
Forward PE	14.79
Dividend	0.17 (1.70%)
Ex-Dividend Date	Jun 19, 2024

Volume	27,242
Average Volume	59,144
Open	9.95
Previous Close	9.99
Day's Range	9.91 - 10.28
52-Week Range	9.40 - 15.14
Beta	0.94
RSI	42.15
Earnings Date	May 22, 2025

About Ion Beam Applications

Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclot...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1986
• Employees: 2,145
• Stock Exchange: Euronext Brussels
• Ticker Symbol: IBAB